Oxeladin

CHEMBL1500276 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
335.5 g/mol
LogP
4.0
Phase
4

An antitussive agent used to suppress non-productive cough by acting centrally on the cough center in the brain. It is used in some countries as an over-the-counter cough suppressant.

Moleküler Ağırlık

335,5000 g/mol

LogP

4,00

TPSA

38,80 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1

InChI

InChI=1S/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1-4H3

Molecular Formula

C20H33NO3

HBD / HBA

- / 4

Döndürülebilir Bağlar

13

Ağır Atomlar

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antitussive agent used to suppress non-productive cough by acting centrally on the cough center in the brain. It is used in some countries as an over-the-counter cough suppressant.

Yes, Oxeladin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1500276. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4619. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.